Annual CFF
-$1.38 B
+$2.07 B+60.06%
31 December 2023
Summary:
Moderna annual cash flow from financing activities is currently -$1.38 billion, with the most recent change of +$2.07 billion (+60.06%) on 31 December 2023. During the last 3 years, it has fallen by -$3.41 billion (-167.73%). MRNA annual CFF is now -167.73% below its all-time high of $2.03 billion, reached on 31 December 2020.MRNA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$11.00 M
-$23.00 M-67.65%
30 September 2024
Summary:
Moderna quarterly cash flow from financing activities is currently $11.00 million, with the most recent change of -$23.00 million (-67.65%) on 30 September 2024. Over the past year, it has increased by +$69.00 million (+118.97%). MRNA quarterly CFF is now -99.20% below its all-time high of $1.38 billion, reached on 30 June 2020.MRNA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$50.00 M
+$69.00 M+57.98%
30 September 2024
Summary:
Moderna TTM cash flow from financing activities is currently -$50.00 million, with the most recent change of +$69.00 million (+57.98%) on 30 September 2024. Over the past year, it has increased by +$1.66 billion (+97.07%). MRNA TTM CFF is now -102.46% below its all-time high of $2.03 billion, reached on 31 December 2020.MRNA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.1% | +119.0% | +97.1% |
| 3 y3 years | -167.7% | +650.0% | -213.6% |
| 5 y5 years | -212.2% | -30.4% | -108.4% |
MRNA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -167.7% | +60.1% | -67.7% | +100.8% | -213.6% | +98.7% |
| 5 y | 5 years | -167.7% | +60.1% | -99.2% | +100.8% | -102.5% | +98.7% |
| alltime | all time | -167.7% | +60.1% | -99.2% | +100.8% | -102.5% | +98.7% |
Moderna Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $11.00 M(-67.6%) | -$50.00 M(-58.0%) |
| June 2024 | - | $34.00 M(+142.9%) | -$119.00 M(-85.5%) |
| Mar 2024 | - | $14.00 M(-112.8%) | -$821.00 M(-40.4%) |
| Dec 2023 | -$1.38 B(-60.1%) | -$109.00 M(+87.9%) | -$1.38 B(-19.3%) |
| Sept 2023 | - | -$58.00 M(-91.3%) | -$1.71 B(-36.6%) |
| June 2023 | - | -$668.00 M(+23.2%) | -$2.69 B(-19.7%) |
| Mar 2023 | - | -$542.00 M(+23.7%) | -$3.35 B(-2.9%) |
| Dec 2022 | -$3.45 B(+295.0%) | -$438.00 M(-57.9%) | -$3.45 B(-11.2%) |
| Sept 2022 | - | -$1.04 B(-21.6%) | -$3.88 B(+36.5%) |
| June 2022 | - | -$1.33 B(+106.7%) | -$2.84 B(+84.6%) |
| Mar 2022 | - | -$642.00 M(-26.5%) | -$1.54 B(+76.5%) |
| Dec 2021 | -$873.00 M(-142.9%) | -$873.00 M(>+9900.0%) | -$873.00 M(-2084.1%) |
| Sept 2021 | - | -$2.00 M(-91.7%) | $44.00 M(-42.1%) |
| June 2021 | - | -$24.00 M(-192.3%) | $76.00 M(-94.9%) |
| Mar 2021 | - | $26.00 M(-40.9%) | $1.48 B(-27.2%) |
| Dec 2020 | $2.03 B(+3809.6%) | $44.00 M(+46.7%) | $2.03 B(+0.6%) |
| Sept 2020 | - | $30.00 M(-97.8%) | $2.02 B(+0.7%) |
| June 2020 | - | $1.38 B(+138.9%) | $2.01 B(+218.6%) |
| Mar 2020 | - | $578.00 M(+1722.3%) | $629.71 M(+1111.0%) |
| Dec 2019 | $52.00 M(-95.8%) | $31.72 M(+100.6%) | $52.00 M(-91.3%) |
| Sept 2019 | - | $15.81 M(+278.5%) | $596.20 M(+4.4%) |
| June 2019 | - | $4.18 M(+1325.6%) | $570.96 M(-15.7%) |
| Mar 2019 | - | $293.00 K(-99.9%) | $677.14 M(-44.8%) |
| Dec 2018 | $1.23 B(>+9900.0%) | $575.91 M(-6207.3%) | $1.23 B(+88.4%) |
| Sept 2018 | - | -$9.43 M(-108.5%) | $651.36 M(-1.4%) |
| June 2018 | - | $110.36 M(-79.9%) | $660.80 M(+19.9%) |
| Mar 2018 | - | $550.00 M(>+9900.0%) | $551.16 M(>+9900.0%) |
| Dec 2017 | $168.00 K(-100.0%) | $435.20 K(+4044.8%) | $1.64 M(+8.3%) |
| Sept 2017 | - | $10.50 K(-98.5%) | $1.51 M(-2.5%) |
| June 2017 | - | $716.00 K(+50.7%) | $1.55 M(+85.7%) |
| Mar 2017 | - | $475.10 K(+53.3%) | $835.00 K(+132.0%) |
| Dec 2016 | $472.91 M(>+9900.0%) | - | - |
| Dec 2016 | - | $309.90 K(+519.8%) | $359.90 K(+619.8%) |
| Sept 2016 | - | $50.00 K(>+9900.0%) | $50.00 K(-95.4%) |
| June 2016 | - | $0.00(0.0%) | $1.09 M(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $1.09 M(-0.1%) |
| Dec 2015 | $1.10 M(-80.8%) | $0.00(-100.0%) | $1.10 M(-2.1%) |
| Sept 2015 | - | $1.09 M(>+9900.0%) | $1.12 M(+5228.6%) |
| June 2015 | - | $0.00(-100.0%) | $21.00 K(+10.5%) |
| Mar 2015 | - | $1000.00(-95.7%) | $19.00 K(-99.7%) |
| Dec 2014 | $5.69 M(<-9900.0%) | $23.00 K(-866.7%) | $5.69 M(+0.3%) |
| Sept 2014 | - | -$3000.00(+50.0%) | $5.68 M(+0.0%) |
| June 2014 | - | -$2000.00(-100.0%) | $5.68 M(+0.0%) |
| Mar 2014 | - | $5.68 M(>+9900.0%) | $5.68 M(<-9900.0%) |
| Dec 2013 | -$2000.00(-100.1%) | $8000.00(-300.0%) | -$2000.00(-102.3%) |
| Sept 2013 | - | -$4000.00(0.0%) | $86.00 K(-4.4%) |
| June 2013 | - | -$4000.00(+100.0%) | $90.00 K(-295.7%) |
| Mar 2013 | - | -$2000.00(-102.1%) | -$46.00 K(-101.8%) |
| Dec 2012 | $2.57 M(-84.0%) | $96.00 K(>+9900.0%) | $2.57 M(-38.6%) |
| Sept 2012 | - | $0.00(-100.0%) | $4.18 M(-20.9%) |
| June 2012 | - | -$140.00 K(-105.4%) | $5.29 M(-62.0%) |
| Mar 2012 | - | $2.61 M(+52.7%) | $13.93 M(-13.1%) |
| Dec 2011 | $16.02 M(+28.4%) | $1.71 M(+55.0%) | $16.02 M(-6.5%) |
| Sept 2011 | - | $1.10 M(-87.0%) | $17.14 M(+6.4%) |
| June 2011 | - | $8.50 M(+80.6%) | $16.11 M(+51.8%) |
| Mar 2011 | - | $4.71 M(+66.3%) | $10.61 M(-15.0%) |
| Dec 2010 | $12.48 M(+157.1%) | $2.83 M(+4189.4%) | $12.48 M(+18.4%) |
| Sept 2010 | - | $66.00 K(-97.8%) | $10.54 M(+0.4%) |
| June 2010 | - | $3.01 M(-54.3%) | $10.50 M(-30.7%) |
| Mar 2010 | - | $6.58 M(+640.5%) | $15.15 M(+212.2%) |
| Dec 2009 | $4.85 M | $888.00 K(+2962.1%) | $4.85 M(+94.5%) |
| Sept 2009 | - | $29.00 K(-99.6%) | $2.50 M(+188.9%) |
| June 2009 | - | $7.66 M(-305.7%) | $864.00 K(-221.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | -$3.72 M(+153.3%) | -$711.00 K(-140.6%) |
| Dec 2008 | $1.75 M(-95.7%) | -$1.47 M(-8.3%) | $1.75 M(-11.7%) |
| Sept 2008 | - | -$1.60 M(-126.3%) | $1.99 M(-51.3%) |
| June 2008 | - | $6.09 M(-583.0%) | $4.08 M(-378.8%) |
| Mar 2008 | - | -$1.26 M(+1.9%) | -$1.46 M(-103.6%) |
| Dec 2007 | $41.01 M(+157.1%) | -$1.24 M(-351.4%) | $41.01 M(-12.2%) |
| Sept 2007 | - | $492.00 K(-9.1%) | $46.74 M(-3.5%) |
| June 2007 | - | $541.00 K(-98.7%) | $48.41 M(-2.5%) |
| Mar 2007 | - | $41.22 M(+818.3%) | $49.65 M(+211.3%) |
| Dec 2006 | $15.95 M(-46.5%) | $4.49 M(+107.1%) | $15.95 M(+22.9%) |
| Sept 2006 | - | $2.17 M(+21.5%) | $12.98 M(-65.3%) |
| June 2006 | - | $1.78 M(-76.2%) | $37.37 M(-0.3%) |
| Mar 2006 | - | $7.51 M(+395.7%) | $37.48 M(+25.8%) |
| Dec 2005 | $29.79 M(-56.2%) | $1.51 M(-94.3%) | $29.79 M(-62.7%) |
| Sept 2005 | - | $26.57 M(+1303.3%) | $79.84 M(+48.9%) |
| June 2005 | - | $1.89 M(-1123.2%) | $53.60 M(-17.6%) |
| Mar 2005 | - | -$185.00 K(-100.4%) | $65.07 M(-4.3%) |
| Dec 2004 | $68.00 M(+467.8%) | $51.56 M(>+9900.0%) | $68.00 M(+300.5%) |
| Sept 2004 | - | $328.00 K(-97.5%) | $16.98 M(-36.3%) |
| June 2004 | - | $13.36 M(+387.1%) | $26.68 M(+76.5%) |
| Mar 2004 | - | $2.74 M(+401.5%) | $15.11 M(+26.2%) |
| Dec 2003 | $11.97 M(+57.9%) | $547.00 K(-94.5%) | $11.97 M(+1.3%) |
| Sept 2003 | - | $10.02 M(+457.8%) | $11.82 M(+466.6%) |
| June 2003 | - | $1.80 M(-558.4%) | $2.09 M(+134.6%) |
| Mar 2003 | - | -$392.00 K(-200.3%) | $889.00 K(-88.3%) |
| Dec 2002 | $7.58 M(-41.7%) | $391.00 K(+34.8%) | $7.58 M(-47.8%) |
| Sept 2002 | - | $290.00 K(-51.7%) | $14.54 M(-3.7%) |
| June 2002 | - | $600.00 K(-90.5%) | $15.09 M(-1.2%) |
| Mar 2002 | - | $6.30 M(-14.1%) | $15.27 M(+17.3%) |
| Dec 2001 | $13.02 M(>+9900.0%) | $7.34 M(+771.1%) | $13.02 M(+129.3%) |
| Sept 2001 | - | $843.00 K(+8.4%) | $5.68 M(+15.5%) |
| June 2001 | - | $778.00 K(-80.8%) | $4.92 M(+20.0%) |
| Mar 2001 | - | $4.05 M(>+9900.0%) | $4.10 M(+9209.1%) |
| Dec 2000 | $44.00 K(-108.8%) | $4000.00(-95.1%) | $44.00 K(-173.3%) |
| Sept 2000 | - | $82.00 K(-295.2%) | -$60.00 K(-88.9%) |
| June 2000 | - | -$42.00 K(<-9900.0%) | -$542.00 K(+8.4%) |
| Mar 2000 | - | $0.00(-100.0%) | -$500.00 K(0.0%) |
| Dec 1999 | -$500.00 K(-135.7%) | -$100.00 K(-75.0%) | -$500.00 K(+25.0%) |
| Sept 1999 | - | -$400.00 K(<-9900.0%) | -$400.00 K(<-9900.0%) |
| June 1999 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1999 | - | $0.00(0.0%) | $1.30 M(-7.1%) |
| Dec 1998 | $1.40 M(-92.0%) | $0.00(0.0%) | $1.40 M(0.0%) |
| Sept 1998 | - | $0.00(-100.0%) | $1.40 M(0.0%) |
| June 1998 | - | $1.30 M(+1200.0%) | $1.40 M(+1300.0%) |
| Mar 1998 | - | $100.00 K(>+9900.0%) | $100.00 K(-99.4%) |
| Dec 1997 | $17.60 M(+309.3%) | $0.00(0.0%) | $17.60 M(0.0%) |
| Sept 1997 | - | $0.00(0.0%) | $17.60 M(+0.6%) |
| June 1997 | - | $0.00(-100.0%) | $17.50 M(-15.5%) |
| Mar 1997 | - | $17.60 M(<-9900.0%) | $20.70 M(+567.7%) |
| Dec 1996 | $4.30 M(+43.3%) | - | - |
| Sept 1996 | - | -$100.00 K(-103.1%) | $3.10 M(+3.3%) |
| June 1996 | $3.00 M(0.0%) | $3.20 M(>+9900.0%) | $3.00 M(+3.4%) |
| Mar 1996 | - | $0.00(0.0%) | $2.90 M(0.0%) |
| Dec 1995 | - | $0.00(-100.0%) | $2.90 M(0.0%) |
| Sept 1995 | - | -$200.00 K(-106.5%) | $2.90 M(-3.3%) |
| June 1995 | $3.00 M(-37.5%) | $3.10 M(>+9900.0%) | $3.00 M(-3100.0%) |
| Mar 1995 | - | $0.00(0.0%) | -$100.00 K(0.0%) |
| Dec 1994 | - | $0.00(-100.0%) | -$100.00 K(-102.2%) |
| Sept 1994 | - | -$100.00 K(<-9900.0%) | $4.50 M(-6.3%) |
| June 1994 | $4.80 M | $0.00(0.0%) | $4.80 M(0.0%) |
| Mar 1994 | - | $0.00(-100.0%) | $4.80 M(0.0%) |
| Dec 1993 | - | $4.60 M(+2200.0%) | $4.80 M(+2300.0%) |
| Sept 1993 | - | $200.00 K | $200.00 K |
FAQ
- What is Moderna annual cash flow from financing activities?
- What is the all time high annual CFF for Moderna?
- What is Moderna annual CFF year-on-year change?
- What is Moderna quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Moderna?
- What is Moderna quarterly CFF year-on-year change?
- What is Moderna TTM cash flow from financing activities?
- What is the all time high TTM CFF for Moderna?
- What is Moderna TTM CFF year-on-year change?
What is Moderna annual cash flow from financing activities?
The current annual CFF of MRNA is -$1.38 B
What is the all time high annual CFF for Moderna?
Moderna all-time high annual cash flow from financing activities is $2.03 B
What is Moderna annual CFF year-on-year change?
Over the past year, MRNA annual cash flow from financing activities has changed by +$2.07 B (+60.06%)
What is Moderna quarterly cash flow from financing activities?
The current quarterly CFF of MRNA is $11.00 M
What is the all time high quarterly CFF for Moderna?
Moderna all-time high quarterly cash flow from financing activities is $1.38 B
What is Moderna quarterly CFF year-on-year change?
Over the past year, MRNA quarterly cash flow from financing activities has changed by +$69.00 M (+118.97%)
What is Moderna TTM cash flow from financing activities?
The current TTM CFF of MRNA is -$50.00 M
What is the all time high TTM CFF for Moderna?
Moderna all-time high TTM cash flow from financing activities is $2.03 B
What is Moderna TTM CFF year-on-year change?
Over the past year, MRNA TTM cash flow from financing activities has changed by +$1.66 B (+97.07%)